On November 17, 2026, a class action complaint was filed against EyePoint, Inc. (“EyePoint” or the “Company”) (NASDAQ: EYPT) on behalf of all persons and entitities that purchased or otherwise acquired EyePoint securities between May 27, 2025 and August 14, 2026, both dates inclusive (the “Class Period”). 

EyePoint Class Action Allegations

According to the complaint, throughout the Class Period, the defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the defendants allegedly made false and/or misleading statements and/or failed to disclose that 1) DURAVYU was less effective than defendants had led investors to believe; 2) accordingly, DURAVYU’s clinical, regulatory, and commercial prospects were overstated; and 3) as a result, the defendants’ public statements were materially false and misleading at all relevant times.

The truth, according to the complaint, began to emerge on August 17, 2026, when EyePoint announced topline results from its Phase 3 LUGANO trial, disclosing that the trial failed to achieve its primary endpoint of change from baseline in best corrected visual acuity (BCVA) compared with the aflibercept control.

On this news, EyePoint’s stock price fell $9.88 per share, or 66.98%, to close at $4.87 per share on August 17, 2026.

January 19, 2027 Lead Plaintiff Deadline

EyePoint investors have until January 17, 2027 to move the Court for appointment as lead plaintiff. Investors do not need to seek appointment as lead plaintiff to remain a member of the proposed class.

EyePoint Investors: Contact Kehoe Law Firm

If you purchased EyePoint securities during the Class Period and suffered financial losses, you are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to learn more about the class action and your legal rights.

For a free, no-obligation legal evaluation, contact:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, as well as ERISA and retirement plan litigation. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]